Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 2Lymphoid 2Breast 2Sarcoma 1Head & Neck 1Endocrine 1

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma 1

Interventions

Cisplatin 314Radiotherapy 139Cetuximab 132pembrolizumab 131Docetaxel 121Carboplatin 119Radiotherapy, Intensity-Modulated 97Fluorouracil 94Paclitaxel 92Nivolumab 64Gemcitabine 50toripalimab 46Radiation 44Drug Therapy 39Capecitabine 39Magnetic Resonance Spectroscopy 38Surgical Procedures, Operative 33camrelizumab 31130-nm albumin-bound paclitaxel 28apatinib 27tislelizumab 26Chemoradiotherapy 26Specimen Handling 25Bevacizumab 24durvalumab 23Albumin-Bound Paclitaxel 23nimotuzumab 22lenvatinib 21Sorafenib 21Platinum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Control Groups × Head & Neck × Clear all
NCT03196869 2017-06-23

the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer

Guiyang Medical University

Phase 2 Unknown
128 enrolled
Head & Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡